THE DEXAMETHASONE SUPPRESSION TEST IN PATIENTS WITH MOOD DISORDERS

Citation
Aj. Rush et al., THE DEXAMETHASONE SUPPRESSION TEST IN PATIENTS WITH MOOD DISORDERS, The Journal of clinical psychiatry, 57(10), 1996, pp. 470-484
Citations number
159
Categorie Soggetti
Psycology, Clinical",Psychiatry,Psychiatry
ISSN journal
01606689
Volume
57
Issue
10
Year of publication
1996
Pages
470 - 484
Database
ISI
SICI code
0160-6689(1996)57:10<470:TDSTIP>2.0.ZU;2-J
Abstract
Background: This study was undertaken to (1) determine whether the end ogenous/nonendogenous mood disorder dichotomy is validated by the dexa methasone suppression test (DST); (2) determine whether other subtypin g schemes (unipolar/bipolar, DSM-III melancholic/nonmelancholic, Winok ur's family history subtypes) relate to the DST; (3) evaluate the rela tive contributions of symptom severity, weight loss, and other factors to DST status; and (4) assess the relative sensitivity of various pos t-dexamethasone cortisol determinations in the detection of dexamethas one nonsuppression. Method: 487 consecutive adult inpatients (N = 131) and outpatients (N = 356) with unipolar (N = 422) or bipolar disorder (N = 65) underwent the 1.0-mg DST. Nonsuppression was defined as at l east one post-dexamethasone cortisol measurement > 4.0 mu g/dL. Result s: Nonsuppression occurred in 27% of all patients with major depressio n and 43% of all bipolar depressed phase patients. For outpatients, de xamethasone nonsuppression occurred in 35.2% of subjects with endogeno us (unipolar + bipolar; N = 145) and 9.0% of those with nonendogenous (unipolar only; N = 211) depressions (single 4 p.m. post-dexamethasone cortisol). For inpatients, dexamethasone nonsuppression was found in 61.5% of subjects with endogenous (N = 104) and 18.5% of those with no nendogenous (N = 27) depressions (three post-dexamethasone cortisol de terminations). For the inpatient and outpatient sample together, the D ST had a sensitivity of 46.2% and a specificity of 89.9% in differenti ating endogenous from nonendogenous major depressive episodes. Weight loss, gender, and symptom severity added little to the endogenous/none ndogenous dichotomy. The Research Diagnostic Criteria (RDC) primary/se condary and Winokur and colleagues' family history subtypes for unipol ar depression were not strongly validated by the DST. The 4 p.m. and 1 1 p.m. samples together detected 91.0% of those inpatients with abnorm al three-sample DST results. The 8 a.m. sample alone detected 30% of t hose, the 4 p.m. sample alone detected 67%, and the 11 p.m. sample alo ne detected 62%. Conclusion: The RDC endogenous/nonendogenous dichotom y was validated by the DST.